Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Tianbaohua Bio-resource Development is a biotechnology company based in Kunming, China, specializing in the sustainable cultivation of Taxus trees and the extraction of taxane-based pharmaceutical ingredients. The company is a significant producer of high-purity paclitaxel and 10-deacetylbaccatin III (10-DAB), which serve as critical active pharmaceutical ingredients (APIs) for anti-cancer medications. By integrating large-scale plantation management with advanced chemical extraction and purification technologies, Yunnan Tianbaohua supports the global supply chain for oncology therapeutics. Their operations include research into plant tissue culture and the development of semi-synthetic routes for taxane derivatives. The company maintains extensive yew tree plantations to ensure a stable and environmentally responsible source of raw materials for its manufacturing processes. Yunnan Tianbaohua's products are utilized by pharmaceutical manufacturers worldwide for the production of chemotherapy drugs targeting various solid tumors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Tianbaohua Bio-resource Development.